-
Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.More >> Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.More >> The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or not exercising.More >> The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or not exercising.More >> When a classmate commits suicide, teens are more likely to consider or attempt suicide themselves, according to a new study. More >> When a classmate commits suicide, teens are more likely to consider or attempt suicide themselves, according to a new study. More >> Pregnant women with specific alterations in two genes may be at increased risk of suffering depression after giving birth, a small new study suggests.More >> Pregnant women with specific alterations in two genes may be at increased risk of suffering depression after giving birth, a small new study suggests.More >> Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.More >> Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> Film star Angelina Jolie will have her ovaries removed to help lower her odds for ovarian cancer, People magazine reported Wednesday.More >> Film star Angelina Jolie will have her ovaries removed to help lower her odds for ovarian cancer, People magazine reported Wednesday.More >> Weight gain in men and women is predicted by two different genetic variations -- so-called polymorphisms, according to a new study from the Netherlands.More >> Weight gain in men and women is predicted by two different genetic variations -- so-called polymorphisms, according to a new study from the Netherlands.More >> The notion of wealthy "sugar daddies" with young, pretty wives and well-heeled "cougar" women with handsome, young husbands may be more fiction than fact, new research suggests.More >> The notion of wealthy "sugar daddies" with young, pretty wives and well-heeled "cougar" women with handsome, young husbands may be more fiction than fact, new research suggests.More >> Close to half of U.S high school students text while driving, a habit that dramatically increases their risk of getting into a potentially fatal car crash, a new study shows.More >> Close to half of U.S high school students text while driving, a habit that dramatically increases their risk of getting into a potentially fatal car crash, a new study shows.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Orexigen Therapeutics, Inc.
SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Cowen & Co. Annual Health Care Conference in Boston. The presentation is scheduled for Monday, March 4, 2013 at 3:30 p.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.
About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.
|
Orexigen Contact:
|
Media Contact:
|
|
McDavid Stilwell
|
Denise Powell
|
|
VP, Corporate Communications and Business Development
|
WCG
|
|
(858) 875-8629
|
(510) 703-9491
|
©2012 PR Newswire. All Rights Reserved.
